Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,265
archived clinical trials in
Rheumatoid Arthritis

Trinity™ BIOLOX Delta™ CoC THR Multi-center Study
Phase 3 Randomized Controlled Study to Demonstrate Safety and Effectiveness of the BIOLOX Delta CoC THR System
Status: Enrolling
Updated:  12/31/1969
Denver Hip and Knee, Inc.
mi
from
Parker, CO
Trinity™ BIOLOX Delta™ CoC THR Multi-center Study
Phase 3 Randomized Controlled Study to Demonstrate Safety and Effectiveness of the BIOLOX Delta CoC THR System
Status: Enrolling
Updated: 12/31/1969
Denver Hip and Knee, Inc.
mi
from
Parker, CO
Click here to add this to my saved trials
Trinity™ BIOLOX Delta™ CoC THR Multi-center Study
Phase 3 Randomized Controlled Study to Demonstrate Safety and Effectiveness of the BIOLOX Delta CoC THR System
Status: Enrolling
Updated:  12/31/1969
Connecticut Joint Replacement Institute (CJRI)
mi
from
Hartford, CT
Trinity™ BIOLOX Delta™ CoC THR Multi-center Study
Phase 3 Randomized Controlled Study to Demonstrate Safety and Effectiveness of the BIOLOX Delta CoC THR System
Status: Enrolling
Updated: 12/31/1969
Connecticut Joint Replacement Institute (CJRI)
mi
from
Hartford, CT
Click here to add this to my saved trials
Trinity™ BIOLOX Delta™ CoC THR Multi-center Study
Phase 3 Randomized Controlled Study to Demonstrate Safety and Effectiveness of the BIOLOX Delta CoC THR System
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic, Jacksonville
mi
from
Jacksonville, FL
Trinity™ BIOLOX Delta™ CoC THR Multi-center Study
Phase 3 Randomized Controlled Study to Demonstrate Safety and Effectiveness of the BIOLOX Delta CoC THR System
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic, Jacksonville
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Trinity™ BIOLOX Delta™ CoC THR Multi-center Study
Phase 3 Randomized Controlled Study to Demonstrate Safety and Effectiveness of the BIOLOX Delta CoC THR System
Status: Enrolling
Updated:  12/31/1969
Florida Orthopaedic Institute
mi
from
Tampa, FL
Trinity™ BIOLOX Delta™ CoC THR Multi-center Study
Phase 3 Randomized Controlled Study to Demonstrate Safety and Effectiveness of the BIOLOX Delta CoC THR System
Status: Enrolling
Updated: 12/31/1969
Florida Orthopaedic Institute
mi
from
Tampa, FL
Click here to add this to my saved trials
Trinity™ BIOLOX Delta™ CoC THR Multi-center Study
Phase 3 Randomized Controlled Study to Demonstrate Safety and Effectiveness of the BIOLOX Delta CoC THR System
Status: Enrolling
Updated:  12/31/1969
FMC Orthopedic Division
mi
from
Tampa, FL
Trinity™ BIOLOX Delta™ CoC THR Multi-center Study
Phase 3 Randomized Controlled Study to Demonstrate Safety and Effectiveness of the BIOLOX Delta CoC THR System
Status: Enrolling
Updated: 12/31/1969
FMC Orthopedic Division
mi
from
Tampa, FL
Click here to add this to my saved trials
Trinity™ BIOLOX Delta™ CoC THR Multi-center Study
Phase 3 Randomized Controlled Study to Demonstrate Safety and Effectiveness of the BIOLOX Delta CoC THR System
Status: Enrolling
Updated:  12/31/1969
Resurgens Orthopaedics
mi
from
Austell, GA
Trinity™ BIOLOX Delta™ CoC THR Multi-center Study
Phase 3 Randomized Controlled Study to Demonstrate Safety and Effectiveness of the BIOLOX Delta CoC THR System
Status: Enrolling
Updated: 12/31/1969
Resurgens Orthopaedics
mi
from
Austell, GA
Click here to add this to my saved trials
Trinity™ BIOLOX Delta™ CoC THR Multi-center Study
Phase 3 Randomized Controlled Study to Demonstrate Safety and Effectiveness of the BIOLOX Delta CoC THR System
Status: Enrolling
Updated:  12/31/1969
OrthoCarolina Hip & Knee Center
mi
from
Charlotte, NC
Trinity™ BIOLOX Delta™ CoC THR Multi-center Study
Phase 3 Randomized Controlled Study to Demonstrate Safety and Effectiveness of the BIOLOX Delta CoC THR System
Status: Enrolling
Updated: 12/31/1969
OrthoCarolina Hip & Knee Center
mi
from
Charlotte, NC
Click here to add this to my saved trials
Trinity™ BIOLOX Delta™ CoC THR Multi-center Study
Phase 3 Randomized Controlled Study to Demonstrate Safety and Effectiveness of the BIOLOX Delta CoC THR System
Status: Enrolling
Updated:  12/31/1969
Memorial Bone & Joint
mi
from
Houston, TX
Trinity™ BIOLOX Delta™ CoC THR Multi-center Study
Phase 3 Randomized Controlled Study to Demonstrate Safety and Effectiveness of the BIOLOX Delta CoC THR System
Status: Enrolling
Updated: 12/31/1969
Memorial Bone & Joint
mi
from
Houston, TX
Click here to add this to my saved trials
Trinity™ BIOLOX Delta™ CoC THR Multi-center Study
Phase 3 Randomized Controlled Study to Demonstrate Safety and Effectiveness of the BIOLOX Delta CoC THR System
Status: Enrolling
Updated:  12/31/1969
Elective Orthopaedic Centre
mi
from
Epsom,
Trinity™ BIOLOX Delta™ CoC THR Multi-center Study
Phase 3 Randomized Controlled Study to Demonstrate Safety and Effectiveness of the BIOLOX Delta CoC THR System
Status: Enrolling
Updated: 12/31/1969
Elective Orthopaedic Centre
mi
from
Epsom,
Click here to add this to my saved trials
The Effect of Corticotrophin (ACTH) in Combination With Methotrexate in Newly Diagnosed Rheumatoid Arthritis Patients
Study of The Effect of Corticotrophin in Combination With Methotrexate in Newly Diagnosed Rheumatoid Arthritis Patients From a Clinical and Structural Perspective As Measured by a Clinical Disease Activity Index Score and Bone Edema, Synovitis and Erosions on Magnetic Resonance Imaging
Status: Enrolling
Updated:  12/31/1969
AARDS Research, Inc
mi
from
Aventura, FL
The Effect of Corticotrophin (ACTH) in Combination With Methotrexate in Newly Diagnosed Rheumatoid Arthritis Patients
Study of The Effect of Corticotrophin in Combination With Methotrexate in Newly Diagnosed Rheumatoid Arthritis Patients From a Clinical and Structural Perspective As Measured by a Clinical Disease Activity Index Score and Bone Edema, Synovitis and Erosions on Magnetic Resonance Imaging
Status: Enrolling
Updated: 12/31/1969
AARDS Research, Inc
mi
from
Aventura, FL
Click here to add this to my saved trials
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated:  12/31/1969
Rheum Assoc of North Alabama /ID# 135926
mi
from
Huntsville, AL
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated: 12/31/1969
Rheum Assoc of North Alabama /ID# 135926
mi
from
Huntsville, AL
Click here to add this to my saved trials
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated:  12/31/1969
AZ Arthritis and Rheum Researc /ID# 135902
mi
from
Phoenix, AZ
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated: 12/31/1969
AZ Arthritis and Rheum Researc /ID# 135902
mi
from
Phoenix, AZ
Click here to add this to my saved trials
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated:  12/31/1969
AZ Arthritis & Rheuma Research /ID# 135931
mi
from
Phoenix, AZ
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated: 12/31/1969
AZ Arthritis & Rheuma Research /ID# 135931
mi
from
Phoenix, AZ
Click here to add this to my saved trials
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated:  12/31/1969
C.V. Mehta MD, Medical Corporation /ID# 124092
mi
from
Hemet, CA
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated: 12/31/1969
C.V. Mehta MD, Medical Corporation /ID# 124092
mi
from
Hemet, CA
Click here to add this to my saved trials
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated:  12/31/1969
Ucsd /Id# 128747
mi
from
La Jolla, CA
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated: 12/31/1969
Ucsd /Id# 128747
mi
from
La Jolla, CA
Click here to add this to my saved trials
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated:  12/31/1969
Desert Medical Advances /ID# 135911
mi
from
Palm Desert, CA
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated: 12/31/1969
Desert Medical Advances /ID# 135911
mi
from
Palm Desert, CA
Click here to add this to my saved trials
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated:  12/31/1969
Orrin Troum, M.D. and Medical /ID# 135933
mi
from
Santa Monica, CA
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated: 12/31/1969
Orrin Troum, M.D. and Medical /ID# 135933
mi
from
Santa Monica, CA
Click here to add this to my saved trials
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated:  12/31/1969
Robin K. Dore MD, Inc /ID# 135906
mi
from
Tustin, CA
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated: 12/31/1969
Robin K. Dore MD, Inc /ID# 135906
mi
from
Tustin, CA
Click here to add this to my saved trials
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated:  12/31/1969
Inland Rheum Clin Trials Inc. /ID# 136716
mi
from
Upland, CA
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated: 12/31/1969
Inland Rheum Clin Trials Inc. /ID# 136716
mi
from
Upland, CA
Click here to add this to my saved trials
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated:  12/31/1969
Desert Valley Medical Group /ID# 135932
mi
from
Victorville, CA
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated: 12/31/1969
Desert Valley Medical Group /ID# 135932
mi
from
Victorville, CA
Click here to add this to my saved trials
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated:  12/31/1969
Denver Arthritis Clinic, PC /ID# 135901
mi
from
Denver, CO
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated: 12/31/1969
Denver Arthritis Clinic, PC /ID# 135901
mi
from
Denver, CO
Click here to add this to my saved trials
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated:  12/31/1969
AARDS Research, Inc. /ID# 135910
mi
from
Aventura, FL
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated: 12/31/1969
AARDS Research, Inc. /ID# 135910
mi
from
Aventura, FL
Click here to add this to my saved trials
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated:  12/31/1969
RASF - Clinical Research /ID# 124082
mi
from
Boca Raton, FL
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated: 12/31/1969
RASF - Clinical Research /ID# 124082
mi
from
Boca Raton, FL
Click here to add this to my saved trials
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated:  12/31/1969
Omega Research Consultants, LLC /ID# 124094
mi
from
DeBary, FL
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated: 12/31/1969
Omega Research Consultants, LLC /ID# 124094
mi
from
DeBary, FL
Click here to add this to my saved trials
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated:  12/31/1969
University of Florida /ID# 124087
mi
from
Jacksonville, FL
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated: 12/31/1969
University of Florida /ID# 124087
mi
from
Jacksonville, FL
Click here to add this to my saved trials
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated:  12/31/1969
Suncoast Research Group, LLC /ID# 137774
mi
from
Miami, FL
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated: 12/31/1969
Suncoast Research Group, LLC /ID# 137774
mi
from
Miami, FL
Click here to add this to my saved trials
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated:  12/31/1969
Omega Research Consultants /ID# 137398
mi
from
Orlando, FL
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated: 12/31/1969
Omega Research Consultants /ID# 137398
mi
from
Orlando, FL
Click here to add this to my saved trials
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated:  12/31/1969
Millennium Research /ID# 135917
mi
from
Ormond Beach, FL
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated: 12/31/1969
Millennium Research /ID# 135917
mi
from
Ormond Beach, FL
Click here to add this to my saved trials
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated:  12/31/1969
Arthritis Center, Inc. /ID# 124090
mi
from
Palm Harbor, FL
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated: 12/31/1969
Arthritis Center, Inc. /ID# 124090
mi
from
Palm Harbor, FL
Click here to add this to my saved trials
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated:  12/31/1969
Lovelace Scientific Resources, Inc. /ID# 128745
mi
from
Venice, FL
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated: 12/31/1969
Lovelace Scientific Resources, Inc. /ID# 128745
mi
from
Venice, FL
Click here to add this to my saved trials
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated:  12/31/1969
North Georgia Rheumatology Grp /ID# 128746
mi
from
Lawrenceville, GA
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated: 12/31/1969
North Georgia Rheumatology Grp /ID# 128746
mi
from
Lawrenceville, GA
Click here to add this to my saved trials
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated:  12/31/1969
Kansas City Internal Medicine /ID# 135916
mi
from
Overland Park, KA
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated: 12/31/1969
Kansas City Internal Medicine /ID# 135916
mi
from
Overland Park, KA
Click here to add this to my saved trials
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated:  12/31/1969
PRN Professional Research Network of Kansas, LLC /ID# 124091
mi
from
Wichita, KA
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated: 12/31/1969
PRN Professional Research Network of Kansas, LLC /ID# 124091
mi
from
Wichita, KA
Click here to add this to my saved trials
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated:  12/31/1969
Klein and Associates, MD., PA /ID# 124086
mi
from
Hagerstown, MD
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated: 12/31/1969
Klein and Associates, MD., PA /ID# 124086
mi
from
Hagerstown, MD
Click here to add this to my saved trials
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated:  12/31/1969
The Center for Rheumatology & /ID# 124077
mi
from
Wheaton, MD
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated: 12/31/1969
The Center for Rheumatology & /ID# 124077
mi
from
Wheaton, MD
Click here to add this to my saved trials
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated:  12/31/1969
Clinical Pharmacology Study Gr /ID# 124079
mi
from
Worcester, MA
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated: 12/31/1969
Clinical Pharmacology Study Gr /ID# 124079
mi
from
Worcester, MA
Click here to add this to my saved trials
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated:  12/31/1969
Justus J. Fiechtner, MD, PC /ID# 124081
mi
from
Lansing, MI
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated: 12/31/1969
Justus J. Fiechtner, MD, PC /ID# 124081
mi
from
Lansing, MI
Click here to add this to my saved trials
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated:  12/31/1969
Summit Medical Group /ID# 124076
mi
from
Clifton, NJ
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated: 12/31/1969
Summit Medical Group /ID# 124076
mi
from
Clifton, NJ
Click here to add this to my saved trials
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated:  12/31/1969
Arthritis and Osteoporosis /ID# 135907
mi
from
Freehold, NJ
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated: 12/31/1969
Arthritis and Osteoporosis /ID# 135907
mi
from
Freehold, NJ
Click here to add this to my saved trials
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated:  12/31/1969
Arthritis Rheumatic Back Disorder /ID# 135913
mi
from
Voorhees, NJ
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated: 12/31/1969
Arthritis Rheumatic Back Disorder /ID# 135913
mi
from
Voorhees, NJ
Click here to add this to my saved trials
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated:  12/31/1969
Arthritis and Osteo Assoc /ID# 132280
mi
from
Las Cruces, NM
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated: 12/31/1969
Arthritis and Osteo Assoc /ID# 132280
mi
from
Las Cruces, NM
Click here to add this to my saved trials
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated:  12/31/1969
DJL Clinical Research, PLLC /ID# 131936
mi
from
Charlotte, NC
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated: 12/31/1969
DJL Clinical Research, PLLC /ID# 131936
mi
from
Charlotte, NC
Click here to add this to my saved trials
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated:  12/31/1969
Cincinnati Rheumatic Disease /ID# 135921
mi
from
Cincinnati, OH
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated: 12/31/1969
Cincinnati Rheumatic Disease /ID# 135921
mi
from
Cincinnati, OH
Click here to add this to my saved trials
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated:  12/31/1969
STAT Research, Inc. /ID# 134906
mi
from
Dayton, OH
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated: 12/31/1969
STAT Research, Inc. /ID# 134906
mi
from
Dayton, OH
Click here to add this to my saved trials
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated:  12/31/1969
Health Research of Oklahoma /ID# 135904
mi
from
Oklahoma City, OK
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated: 12/31/1969
Health Research of Oklahoma /ID# 135904
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated:  12/31/1969
East Penn Rheumatology Assoc /ID# 135920
mi
from
Bethlehem, PA
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated: 12/31/1969
East Penn Rheumatology Assoc /ID# 135920
mi
from
Bethlehem, PA
Click here to add this to my saved trials
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated:  12/31/1969
Altoona Ctr Clinical Res /ID# 124089
mi
from
Duncansville, PA
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated: 12/31/1969
Altoona Ctr Clinical Res /ID# 124089
mi
from
Duncansville, PA
Click here to add this to my saved trials
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated:  12/31/1969
Emkey Arthritis and Osteo Clin /ID# 135908
mi
from
Wyomissing, PA
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated: 12/31/1969
Emkey Arthritis and Osteo Clin /ID# 135908
mi
from
Wyomissing, PA
Click here to add this to my saved trials
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated:  12/31/1969
Dr. Ramesh Gupta /ID# 128744
mi
from
Memphis, TN
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated: 12/31/1969
Dr. Ramesh Gupta /ID# 128744
mi
from
Memphis, TN
Click here to add this to my saved trials
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated:  12/31/1969
Austin Rheum. Research /ID# 124083
mi
from
Austin, TX
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated: 12/31/1969
Austin Rheum. Research /ID# 124083
mi
from
Austin, TX
Click here to add this to my saved trials